Literature DB >> 12938009

Helicobacter pylori genotypes in Russia.

K Momynaliev1, O Smirnova, L Kudryavtseva, V Govorun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12938009     DOI： 10.1007/s10096-003-0987-2

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  5 in total

1.  The efficacy of laboratory diagnosis of Helicobacter pylori infections in gastric biopsy specimens is related to bacterial density and vacA, cagA, and iceA genotypes.

Authors:  L J van Doorn; Y Henskens; N Nouhan; A Verschuuren; R Vreede; P Herbink; G Ponjee; K van Krimpen; R Blankenburg; J Scherpenisse; W Quint
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin.

Authors:  M Gerhard; N Lehn; N Neumayer; T Borén; R Rad; W Schepp; S Miehlke; M Classen; C Prinz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

3.  Expanding allelic diversity of Helicobacter pylori vacA.

Authors:  L J van Doorn; C Figueiredo; R Sanna; S Pena; P Midolo; E K Ng; J C Atherton; M J Blaser; W G Quint
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

4.  Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial.

Authors:  C Papi; A Ciaco; M Koch; L Capurso
Journal:  Aliment Pharmacol Ther       Date:  1995-02       Impact factor: 8.171

5.  Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori.

Authors:  L J van Doorn; C Figueiredo; R Sanna; A Plaisier; P Schneeberger; W de Boer; W Quint
Journal:  Gastroenterology       Date:  1998-07       Impact factor: 22.682
  5 in total
  1 in total

1.  Mixed infection with cagA positive and cagA negative strains of Helicobacter pylori lowers disease burden in The Gambia.

Authors:  Ousman Secka; Martin Antonio; Douglas E Berg; Mary Tapgun; Christian Bottomley; Vivat Thomas; Robert Walton; Tumani Corrah; Julian E Thomas; Richard A Adegbola
Journal:  PLoS One       Date:  2011-11-29       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.